🔎 Trials Near Me

Home › Chronic Lymphocytic Leukemia › New Jersey › Newark

Chronic Lymphocytic Leukemia clinical trials in Newark, NJ

7 studies for Chronic Lymphocytic Leukemia are looking for participants at sites in and around Newark (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

RecruitingPhase 3
  • Atlantic Health System Morristown Medical Center ( Site 5445), Morristown · 17 mi away
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT05947851

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RecruitingObservational studyHealthy volunteers welcome
  • Morristown Medical Center, Morristown · 17 mi away
Ages 40 to 75 · All sexes · Updated Nov 4, 2026 · NCT05334069

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

RecruitingPhase 3
  • Cooperman Barnabas Medical Center, Livingston · 9 mi away
Ages 65 and older · All sexes · Updated Nov 3, 2026 · NCT07321652

Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies

RecruitingPhase 1/2
  • New Jersey Cancer Care, Belleville · 4 mi away
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07520006

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

RecruitingPhase 3
  • Carol G Simon Cancer Center, Morristown · 17 mi away
Ages 18 and older · All sexes · Updated Oct 14, 2026 · NCT07648264

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

RecruitingPhase 1/2
  • Atlantic Health, Morristown · 17 mi away
Ages 12 and older · All sexes · Updated Sep 3, 2026 · NCT04588922

A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies

RecruitingPhase 2
  • Summit Medical Group, Florham Park · 12 mi away
Ages 18 and older · All sexes · Updated Jun 12, 2026 · NCT07271667

Chronic Lymphocytic Leukemia trials in other cities

Other studies in Newark

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.